These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas. Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935 [TBL] [Abstract][Full Text] [Related]
12. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer. Lynch DH Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008 [TBL] [Abstract][Full Text] [Related]
13. Prospects for the use of NK cells in immunotherapy of human cancer. Ljunggren HG; Malmberg KJ Nat Rev Immunol; 2007 May; 7(5):329-39. PubMed ID: 17438573 [TBL] [Abstract][Full Text] [Related]
14. Immunogenic anti-cancer chemotherapy as an emerging concept. Haynes NM; van der Most RG; Lake RA; Smyth MJ Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in clinical hematology and oncology. Nagorsen D; Thiel E Curr Opin Investig Drugs; 2007 Dec; 8(12):996-1001. PubMed ID: 18058570 [TBL] [Abstract][Full Text] [Related]
16. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model. Berinstein NL Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743 [TBL] [Abstract][Full Text] [Related]
17. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies. Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803 [TBL] [Abstract][Full Text] [Related]
18. Imaging the immune response to monitor tumor immunotherapy. Wang Q; Ornstein M; Kaufman HL Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763 [TBL] [Abstract][Full Text] [Related]
19. New frontiers in cell-based immunotherapy of cancer. D'Elios MM; Del Prete G; Amedei A Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938 [TBL] [Abstract][Full Text] [Related]
20. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models. Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]